Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Correlates of protection against HIV infection in HIV Exposed Seronegative subjects
FY 2010-11
Summary
The human immunodeficiency virus (HIV) has been responsible for an estimated 25 million deaths worldwide. Despite extensive research over the past quarter century, an effective vaccine remains elusive. Some individuals remain HIV seronegative despite multiple exposures to HIV (HIV Exposed Seronegative or HESN). Understanding the underlying cause(s) of persistent seronegativity despite HIV exposure is important for identifying correlates of immune protection and may inform the rational design of an effective preventive HIV vaccine. Natural Killer (NK) cells act in early and late stages of HIV infection, releasing anti-viral factors and lysing virus infected cells directly or by Antibody Dependent Cellular Cytotoxicity (ADCC). Stimulated NK cells from HESN have been shown to have higher cytolytic activity compared to those from low risk controls, suggesting a role for NK cells in protection from infection. We have access to cell and plasma samples from HESN exposed through injection drug use. When HIV buds from infected cells it brings with it cell membrane proteins such as major histocompatibility complex (MHC) class II molecules among others. These are highly polymorphic and immunogenic and may induce antibodies (Abs) to non self MHC class II when HESN are exposed to HIV through drug use. We hypothesize that such Abs are induced and function in ADCC and Antibody Dependent Cell-mediated Viral Inhibition (ADCVI) to bridge cells with anti-viral activity to HIV infected targets leading to the elimination of these cells and early containment of HIV. This project aims to examine whether HESN will be more likely than low risk controls to have Abs directed to allogeneic MHC alleles and whether MHC-specific antibodies in HESN will be able to mediate ADCC or ADCVI against HIV infected targets. Information arising from this project would be relevant to vaccine design by finding a role for anti-MHC Abs in protection from infection through an NK mediated mechanism.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
225068
Name
Zanoni Pilar
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Correlates of protection against HIV infection in HIV Exposed Seronegative subjects
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Hiv/Aids; Hla; Innate Immunity; Nk Cell Function; Protection From Infection
Abstract
The human immunodeficiency virus (HIV) has been responsible for an estimated 25 million deaths worldwide. Despite extensive research over the past quarter century, an effective vaccine remains elusive. Some individuals remain HIV seronegative despite multiple exposures to HIV (HIV Exposed Seronegative or HESN). Understanding the underlying cause(s) of persistent seronegativity despite HIV exposure is important for identifying correlates of immune protection and may inform the rational design of an effective preventive HIV vaccine. Natural Killer (NK) cells act in early and late stages of HIV infection, releasing anti-viral factors and lysing virus infected cells directly or by Antibody Dependent Cellular Cytotoxicity (ADCC). Stimulated NK cells from HESN have been shown to have higher cytolytic activity compared to those from low risk controls, suggesting a role for NK cells in protection from infection. We have access to cell and plasma samples from HESN exposed through injection drug use. When HIV buds from infected cells it brings with it cell membrane proteins such as major histocompatibility complex (MHC) class II molecules among others. These are highly polymorphic and immunogenic and may induce antibodies (Abs) to non self MHC class II when HESN are exposed to HIV through drug use. We hypothesize that such Abs are induced and function in ADCC and Antibody Dependent Cell-mediated Viral Inhibition (ADCVI) to bridge cells with anti-viral activity to HIV infected targets leading to the elimination of these cells and early containment of HIV. This project aims to examine whether HESN will be more likely than low risk controls to have Abs directed to allogeneic MHC alleles and whether MHC-specific antibodies in HESN will be able to mediate ADCC or ADCVI against HIV infected targets. Information arising from this project would be relevant to vaccine design by finding a role for anti-MHC Abs in protection from infection through an NK mediated mechanism.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zanoni, Pilar
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~